MedPath

Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients

Phase 2
Conditions
Periodontitis
Diabetes Mellitus Type 2 With Hyperglycemia
Interventions
Other: placebo
Drug: Vitamin C 500 MG Oral Capsule
Registration Number
NCT03269799
Lead Sponsor
Mahidol University
Brief Summary

Periodontitis patients with uncontrolled type 2 diabetes mellitus will receive non-surgical periodontal treatment and then be supplemented with daily 500 mg vitamin C (test group) or placebo (control group) for 2 months. Clinical parameters will be retrieved at baseline, at the end of week 4 and at the end of week 8.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • uncontrolled type 2 diabetes mellitus
  • periodontitis
Read More
Exclusion Criteria
  • complications from diabetes mellitus, e.g., renal insufficiency
  • receive insulin
  • diseases that interfere with wound healing, e.g., HIV
  • receive one of the followings: tetracycline, acetaminophen, NSAID, warfarin, aluminum-containing antacids, barbiturates, phenobarbital, pentobarbital, secobarbital, hormone replacement therapy, chemotherapeutic drug, protease inhibitor
  • receive other vitamins or antibiotics within 6 months
  • smoking
  • pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupplaceboplacebo
test groupVitamin C 500 MG Oral Capsulevitamin C 500 mg oral capsule
Primary Outcome Measures
NameTimeMethod
sulcus bleeding indexbaseline, change from baseline sulcus bleeding index at 4 weeks, change from baseline sulcus bleeding index at 8 weeks

bleeding upon probing of gingival sulcus from the most severe periodontitis tooth

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Burapha University Hospital

🇹🇭

Chon Buri, Thailand

© Copyright 2025. All Rights Reserved by MedPath